GFS-202-A

N/A

Report date: 2025/06/04 16:49:36

Base Information

Drug NameGFS-202-A

Drug Alias NameGFS202AGFS-202-A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionGrowth/differentiation factor 15 inhibitorsInterleukin-6 inhibitors

TargetsGrowth/differentiation factor 15Interleukin-6

Therapy Area/IndicationsCachexia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesGenfleet Therapeutics (Shanghai) Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGenfleet Therapeutics (Shanghai) Co Ltd

Inactive CompaniesN/A

Active IndicationsCachexia

Inactive IndicationsN/A

Other Information

ATC CodeN/A